nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Big-5 Quasi-Experimental designs
|
Tugwell, Peter |
|
2017 |
89 |
C |
p. 1-3 3 p. |
artikel |
2 |
CARE guidelines for case reports: explanation and elaboration document
|
Riley, David S. |
|
2017 |
89 |
C |
p. 218-235 18 p. |
artikel |
3 |
Comparator choice in cariology trials limits conclusions on the comparative effectiveness of caries interventions
|
Schwendicke, Falk |
|
2017 |
89 |
C |
p. 209-217 9 p. |
artikel |
4 |
Corrigendum to “The Mini-OAKHQOL for knee and hip osteoarthritis quality of life was obtained following recent shortening guidelines” [J Clin Epidemiol 2016;69:70–78]
|
Guillemin, Francis |
|
2017 |
89 |
C |
p. 240-241 2 p. |
artikel |
5 |
Decisional conflict screening for a diversity of primary care decisions. Are we SURE yet?
|
Décary, Simon |
|
2017 |
89 |
C |
p. 238-239 2 p. |
artikel |
6 |
Editorial Board
|
|
|
2017 |
89 |
C |
p. IFC- 1 p. |
artikel |
7 |
Minimal important difference to infer changes in health-related quality of life—a systematic review
|
Jayadevappa, Ravishankar |
|
2017 |
89 |
C |
p. 188-198 11 p. |
artikel |
8 |
Montreal Accord on Patient-Reported Outcomes (PROs) use series – Commentary
|
Cook, Karon F. |
|
2017 |
89 |
C |
p. 111-113 3 p. |
artikel |
9 |
Montreal Accord on Patient-Reported Outcomes (PROs) use series – Paper 9: anonymization and ethics considerations for capturing and sharing patient reported outcomes
|
Arbuckle, Luk |
|
2017 |
89 |
C |
p. 168-172 5 p. |
artikel |
10 |
Montreal Accord on Patient-Reported Outcomes (PROs) use series – Paper 6: creating national initiatives to support development and use—the PROMIS example
|
Bartlett, Susan J. |
|
2017 |
89 |
C |
p. 148-153 6 p. |
artikel |
11 |
Montreal Accord on Patient-Reported Outcomes (PROs) use series – Paper 1: introduction
|
Bartlett, Susan J. |
|
2017 |
89 |
C |
p. 114-118 5 p. |
artikel |
12 |
Montreal Accord on Patient-Reported Outcomes (PROs) use series–Paper 7: modern perspectives of measurement validation emphasize justification of inferences based on patient reported outcome scores
|
Sawatzky, Richard |
|
2017 |
89 |
C |
p. 154-159 6 p. |
artikel |
13 |
Montreal Accord on Patient-Reported Outcomes (PROs) use series – Paper 5: patient-reported outcomes can be linked to epidemiologic measures to monitor populations and inform public health decisions
|
Mamiya, Hiroshi |
|
2017 |
89 |
C |
p. 142-147 6 p. |
artikel |
14 |
Montreal Accord on Patient-Reported Outcomes (PROs) use series – Paper 3: patient-reported outcomes can facilitate shared decision-making and guide self-management
|
Noonan, Vanessa K. |
|
2017 |
89 |
C |
p. 125-135 11 p. |
artikel |
15 |
Montreal Accord on Patient-Reported Outcomes (PROs) use series – Paper 4: patient-reported outcomes can inform clinical decision making in chronic care
|
Bingham III, Clifton O. |
|
2017 |
89 |
C |
p. 136-141 6 p. |
artikel |
16 |
Montreal Accord on Patient-Reported Outcomes (PROs) use series – Paper 8: patient-reported outcomes in electronic health records can inform clinical and policy decisions
|
Ahmed, Sara |
|
2017 |
89 |
C |
p. 160-167 8 p. |
artikel |
17 |
Montreal Accord on Patient-Reported Outcomes (PROs) use series – Paper 2: terminology proposed to measure what matters in health
|
Mayo, Nancy E. |
|
2017 |
89 |
C |
p. 119-124 6 p. |
artikel |
18 |
Patients and primary care providers identify opportunities for personalized (N-of-1) trials in the mobile health era
|
Kronish, Ian M. |
|
2017 |
89 |
C |
p. 236-237 2 p. |
artikel |
19 |
Primary endpoint discrepancies were found in one in ten clinical drug trials. Results of an inception cohort study
|
van den Bogert, Cornelis A. |
|
2017 |
89 |
C |
p. 199-208 10 p. |
artikel |
20 |
Quasi-experimental study designs series—paper 5: a checklist for classifying studies evaluating the effects on health interventions—a taxonomy without labels
|
Reeves, Barnaby C. |
|
2017 |
89 |
C |
p. 30-42 13 p. |
artikel |
21 |
Quasi-experimental study designs series—paper 7: assessing the assumptions
|
Bärnighausen, Till |
|
2017 |
89 |
C |
p. 53-66 14 p. |
artikel |
22 |
Quasi-experimental study designs series—paper 9: collecting data from quasi-experimental studies
|
Aloe, Ariel M. |
|
2017 |
89 |
C |
p. 77-83 7 p. |
artikel |
23 |
Quasi-experimental study designs series—paper 2: complementary approaches to advancing global health knowledge
|
Geldsetzer, Pascal |
|
2017 |
89 |
C |
p. 12-16 5 p. |
artikel |
24 |
Quasi-experimental study designs series—paper 8: identifying quasi-experimental studies to inform systematic reviews
|
Glanville, Julie |
|
2017 |
89 |
C |
p. 67-76 10 p. |
artikel |
25 |
Quasi-experimental study designs series—paper 1: introduction: two historical lineages
|
Bärnighausen, Till |
|
2017 |
89 |
C |
p. 4-11 8 p. |
artikel |
26 |
Quasi-experimental study designs series—paper 13: realizing the full potential of quasi-experiments for health research
|
Rockers, Peter C. |
|
2017 |
89 |
C |
p. 106-110 5 p. |
artikel |
27 |
Quasi-experimental study designs series—paper 6: risk of bias assessment
|
Waddington, Hugh |
|
2017 |
89 |
C |
p. 43-52 10 p. |
artikel |
28 |
Quasi-experimental study designs series–paper 12: strengthening global capacity for evidence synthesis of quasi-experimental health systems research
|
Rockers, Peter C. |
|
2017 |
89 |
C |
p. 98-105 8 p. |
artikel |
29 |
Quasi-experimental study designs series—paper 11: supporting the production and use of health systems research syntheses that draw on quasi-experimental study designs
|
Lavis, John N. |
|
2017 |
89 |
C |
p. 92-97 6 p. |
artikel |
30 |
Quasi-experimental study designs series—paper 10: synthesizing evidence for effects collected from quasi-experimental studies presents surmountable challenges
|
Becker, Betsy Jane |
|
2017 |
89 |
C |
p. 84-91 8 p. |
artikel |
31 |
Quasi-experimental study designs series—paper 3: systematic generation of evidence through public policy evaluation
|
Frenk, Julio |
|
2017 |
89 |
C |
p. 17-20 4 p. |
artikel |
32 |
Quasi-experimental study designs series—paper 4: uses and value
|
Bärnighausen, Till |
|
2017 |
89 |
C |
p. 21-29 9 p. |
artikel |
33 |
Series: Pragmatic trials and real world evidence: Paper 4. Informed consent
|
Kalkman, Shona |
|
2017 |
89 |
C |
p. 181-187 7 p. |
artikel |
34 |
Series: Pragmatic trials and real world evidence: Paper 3. Patient selection challenges and consequences
|
Oude Rengerink, Katrien |
|
2017 |
89 |
C |
p. 173-180 8 p. |
artikel |
35 |
Table of Contents
|
|
|
2017 |
89 |
C |
p. A3-A6 nvt p. |
artikel |